|
|
| 华领医药, 02552.HK - 财务比率 |
2021-12 |
2020-12 |
2019-12 |
2018-12 |
2017-12 |
2016-12 |
| 变现能力分析 |
| 流动比率(倍) |
6.59 |
9.81 |
10.3 |
18.99 |
5.4 |
8.88 |
| 速动比率(倍) |
6.59 |
9.81 |
10.3 |
18.99 |
5.4 |
8.88 |
| 偿债能力分析 |
| 长期债项/股东权益(%) |
12.93 |
9.45 |
7.35 |
0.0 |
0.0 |
0.0 |
| 总债项/股东权益(%) |
15.88 |
11.02 |
8.48 |
0.0 |
0.0 |
0.0 |
| 总债项/资本运用(%) |
8.98 |
7.39 |
7.85 |
0.0 |
0.0 |
0.0 |
| 投资回报分析 |
| 股东权益回报率(%) |
0.0 |
0.0 |
0.0 |
0.0 |
28.59 |
53.92 |
| 资本运用回报率(%) |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| 总资产回报率(%) |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| 盈利能力分析 |
| 经营利润率(%) |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| 税前利润率(%) |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| 边际利润率(%) |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| 营运能力分析 |
| 存货周转率(倍) |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| 投资收益分析 |
| 派息比率(%) |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| 相关统计 |
| 财政年度周最高价 |
6.48 |
9.0 |
8.92 |
8.99 |
0.0 |
0.0 |
| 财政年度周最低价 |
3.5 |
2.47 |
3.9 |
6.52 |
0.0 |
0.0 |
| 财政年度最高市盈率(倍) |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| 财政年度最低市盈率(倍) |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| 财政年度最高周息率(%) |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| 财政年度最低周息率(%) |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
|
|